Peptavo is Accredited for 20 CME hours.Peptavo is Jointly Accredited for 20 CME hours. Learn more about accreditation
Get volume discounts if you are getting 3 or more clinicians certified
Book a Call

Compounded peptides should be stored as the pharmacy's label directs, usually refrigerated at 2°C to 8°C, and used before the beyond-use date the pharmacy assigned. Reconstituting a vial in the clinic counts as compounding under USP 797, with much shorter limits. Here is how to receive, store, and prepare them.

Compounded peptides should be stored as the dispensing pharmacy's label directs, which for most products means refrigeration at 2°C to 8°C (36°F to 46°F), protection from light, and no freezing unless the label says otherwise, and used before the beyond-use date the pharmacy assigned. Reconstituting a compounded vial in the clinic is itself compounding under USP General Chapter 797, so a vial the clinic mixes and keeps for later doses carries much shorter limits than one the pharmacy prepared.
Peptides are fragile molecules that degrade with heat and time in solution, and a compounded injectable stays sterile only as long as everyone who handles it keeps it that way. This guide covers the two forms peptides arrive in, what a beyond-use date means, the clinic refrigerator, reconstitution, multi-dose vials, disposal, and what patients need to know before a vial goes home.
Status as of October 29, 2026. The pharmacy's label and instructions govern any specific preparation. This guide covers the general rules and USP 797 as revised in 2023; your state board of pharmacy decides how 797 applies to a clinic. Storage does not make a product lawful: whether a peptide may be compounded at all is covered in our map of the FDA compounding categories.
Compounded peptides come in two forms, and many storage decisions follow from which one is in the box.
| Liquid (ready to inject) | Lyophilized (freeze-dried powder) | |
|---|---|---|
| What arrives | A solution in a vial, usually with a patient's name on it | A pellet or film in a sealed vial, often with a separate diluent |
| Shipping | Overnight, refrigerated, in the pharmacy's insulated shipper with cold packs | Tolerates short transit at room temperature, per the pharmacy's data |
| On receipt | Refrigerate | Store per the label, commonly refrigerated and away from light |
| Dating | The pharmacy's beyond-use date, which depends on how it was made and tested | The pharmacy's beyond-use date for the dry vial, then a separate limit once reconstituted |
| Main risk | Warm arrival after a delayed shipment | Errors and contamination during reconstitution |
Long shelf lives quoted for dry peptide powder come from manufacturers and research suppliers. A vial compounded by a 503A pharmacy carries a beyond-use date set under 797, which runs from days to a few months. A 503B outsourcing facility can assign a longer expiration date when its own stability studies support it.
A beyond-use date is the date or time after which a compounded preparation may not be used. An expiration date belongs to an FDA-approved product and rests on the manufacturer's stability studies. A BUD is set by whoever compounds the preparation under USP General Chapter 797, and how long it may run depends on where and how the preparation was made and tested.
797 sorts sterile preparations into three categories. Category 1 is prepared outside a cleanroom suite and is limited to 12 hours at room temperature or 24 hours refrigerated. Category 3 requires sterility testing, endotoxin testing where it applies, and stability data, and can run to 60 days at room temperature, 90 refrigerated, and 120 frozen for an aseptically processed preparation. Many compounded peptides are Category 2, and the limits for an aseptically processed Category 2 preparation look like this:
| How it was made | Room temperature | Refrigerator | Freezer |
|---|---|---|---|
| Sterile starting components, no sterility test | 4 days | 10 days | 45 days |
| One or more nonsterile starting components, no sterility test | 1 day | 4 days | 45 days |
| Passed a USP 71 sterility test | 30 days | 45 days | 60 days |
797 defines room temperature as 20°C to 25°C, the refrigerator as 2°C to 8°C, and the freezer as -25°C to -10°C. When a preparation made from nonsterile starting components carries a date that requires sterility testing, it must also pass endotoxin testing.
Peptide bulk substance often reaches the pharmacy as a nonsterile powder. A peptide made from nonsterile components and labeled with a refrigerated BUD of 45 days or more should therefore have passing sterility and endotoxin results behind it, or Category 3 conditions with stability data. Ask for the reports. A long date without them is the red flag our compounding pharmacy guide describes.
Open cold-chain shipments the day they arrive. Check that the cold packs are still cold and any temperature indicator is within range, compare the contents against the order and the patient name on each label, and record the lot numbers and BUDs. Refrigerate immediately.
Quarantine a liquid shipment that arrives warm, photograph the packaging and indicator, and call the pharmacy before using any of it. The pharmacy's stability data decides whether a short excursion is acceptable, and the usual answer is a replacement. Liquid product shipped late in the week is the most common cause, so ask the pharmacy to ship early in the week unless overnight delivery is guaranteed. For practices shipping to patients' homes, our guide to prescribing peptides by telehealth covers the pharmacy licensing that decides where a vial can go.
| Element | Standard |
|---|---|
| Unit | A dedicated medication refrigerator with no food, drink, or specimens. CDC's vaccine guidance says never to use a dormitory-style or bar-style combined unit. |
| Temperature | 2°C to 8°C (36°F to 46°F). A freezer, where a label calls for one, runs at -25°C to -10°C. |
| Monitoring | A digital data logger with a buffered probe in the center of the unit and a min-max display, read and recorded at the start of each working day |
| Placement | Two to three inches from the walls, floor, ceiling, and door, never on door shelves or under a cooling vent. Keep vials in their cartons to block light. |
| Organization | Patient-specific 503A vials in labeled bins by patient, 503B office stock kept separately, earliest BUD at the front |
| Excursions | A written plan: quarantine, record the time and temperature, call the pharmacy before using anything that was out of range |
The CDC vaccine storage and handling toolkit sets out the same standards and is a good template for the temperature and excursion logs.
The 503A and 503B separation matters legally as well as practically. A vial dispensed by a 503A pharmacy is for the patient named on its label. A 503B outsourcing facility can supply office stock without a patient-specific prescription. Our guide to 503A vs. 503B pharmacies covers why.
797 counts reconstituting as compounding. Its one exception, preparing a product according to its approved labeling, needs FDA-approved labeling that states the diluent, strength, container, and storage time, and a compounded vial has none. So when clinic staff reconstitute a compounded peptide, most state boards treat the clinic as the compounder, responsible for the preparation and its BUD.
That leaves three workable patterns. Staff can reconstitute a dose for one patient and begin giving it within four hours, under 797's immediate-use provision, which also limits the preparation to no more than three sterile products and requires discarding what is left. A clinic with only a segregated compounding area and no cleanroom suite is limited to Category 1 dates of 12 hours at room temperature or 24 hours refrigerated for anything it keeps. For multi-day use, the cleaner routes are a liquid preparation the pharmacy made and dated, or a lyophilized vial and diluent dispensed to the patient to reconstitute at home on the pharmacy's instructions. Confirm with your board of pharmacy which pattern your state allows.
Whoever does the mixing, the diluent and its volume decide the concentration, and every dose drawn afterward depends on getting both right.
| Diluent | When it is used |
|---|---|
| Bacteriostatic water (0.9% benzyl alcohol) | The usual choice for a vial meant for several doses, because the preservative limits microbial growth between punctures. Labeled not for use in neonates. |
| Sterile water for injection | Single-dose use, a patient sensitive to benzyl alcohol, or a peptide incompatible with the preservative. With no preservative, treat the vial as single-dose. |
| Sodium chloride 0.9% | When the pharmacy's instructions call for it |
When in doubt, the pharmacy that compounded the peptide is the authority on diluent and volume. Swab the stopper and let the alcohol dry, equalize the pressure in the vial, inject the diluent slowly down the inside wall, and swirl gently until the powder dissolves, avoiding vigorous shaking and foaming. Label the vial with the date and time, the concentration, the diluent, your initials, and the discard time.
A vial that will be punctured more than once should belong to one patient. CDC's injection safety guidance says to assign multi-dose vials to a single patient whenever possible, to dedicate any vial that enters a treatment room to that patient, and to discard an opened vial within 28 days unless the manufacturer specifies a different date.
That 28-day figure is written for manufactured multi-dose vials. For a compounded preparation, 797 allows use for up to 28 days after first puncture only when the preserved preparation has passed antimicrobial effectiveness testing under USP 51, and never past its BUD. A preservative in the diluent does not by itself meet that test. Ask the pharmacy for the in-use date in writing.
Use a new sterile needle and syringe for every entry and every injection. A reused needle dulls, hurts more, and carries contamination into the vial. In one case taught in the course, a patient injecting a repair peptide into his calf developed cellulitis because he was not cleaning the skin first. The steps that prevent it take seconds: wash hands, swab the stopper, swab the site, let both dry, use a fresh needle, and dispose of it at once.
OSHA's bloodborne pathogens standard, 29 CFR 1910.1030, prohibits bending, recapping, or removing contaminated needles unless no alternative is feasible, and requires used sharps to go into puncture-resistant containers as soon as possible. Full containers go out through your medical waste vendor.
Patients injecting at home need a sharps container too. FDA's guidance on disposing of used needles covers what to use and how local disposal programs work. Expired or compromised vials in the clinic go through your pharmaceutical waste vendor under state rules, and the destruction is logged.
Before a vial leaves the clinic, the patient should know to refrigerate it on arrival home, keep it in its carton, avoid freezing and vigorous shaking, and discard it on the date on the label. For travel, an insulated case with cold packs maintains refrigeration, and patients flying should carry the vial, supplies, and a copy of the prescription in hand luggage. Give all of it in writing on the patient's reference sheet, and confirm it with a teach-back before the patient leaves.
Quarantine any vial that is cloudy when it should be clear, contains particles, has changed color, or arrived out of temperature range, and call the pharmacy. Report a suspected product problem or a serious adverse event to FDA MedWatch, which takes reports on compounded drugs as well as approved ones.
A repeated local reaction does not always mean a bad vial. Benzyl alcohol, the injection technique, and the peptide itself can each cause one, and the pharmacy can tell you whether other patients on the same lot have reported anything. Patients arriving from the grey market may already be sensitized by whatever they injected before, which is worth asking about at the first visit.
| Record | What it should show |
|---|---|
| Receipt | Date, pharmacy, patient or stock, lot number, BUD, and condition on arrival |
| Temperature | Daily min-max readings with initials, and every excursion with its outcome |
| Preparation | For anything reconstituted in the clinic: date and time, diluent and volume, concentration, who mixed it, and the discard time |
| Dispensing | Which vials went home with which patient, and the instructions given |
| Disposal | What was discarded, why, and how |
Peptavo's peptide course for physicians includes a full module on reconstitution, dose calculation, injection technique, and storage, with video demonstrations and the patient reference sheet, and is designated for up to 20 AMA PRA Category 1 Credits™. The same course is open to nurses and nurse practitioners, who handle most of this work in a clinic.
It depends on who reconstituted them. A preparation the pharmacy made carries the pharmacy's BUD, and a preserved multi-dose vial can be used up to 28 days after first puncture only if it passed USP 51 testing, and never past that BUD. A vial reconstituted in a clinic without a cleanroom suite is limited to 24 hours refrigerated under 797.
Usually. Most pharmacies label lyophilized peptides for refrigeration and protection from light, though dry powder tolerates short periods at room temperature in shipping. Follow the label and refrigerate on receipt.
Only if the pharmacy's labeling says to. Freezing and thawing can degrade a peptide in solution, and a frozen BUD is the compounder's to assign.
Bacteriostatic water is the usual choice for a vial meant for several doses, because its benzyl alcohol preservative limits microbial growth. Sterile water suits single-dose use or a patient sensitive to benzyl alcohol, and saline is used when the pharmacy directs it. Follow the pharmacy's instructions for the specific preparation.
A 503A vial is for the patient named on its label. A 503B facility can supply office stock for use across patients, and CDC still advises dedicating a multi-dose vial to a single patient whenever possible.
Quarantine the vials, document the packaging and any temperature indicator, and ask the pharmacy before using any of it. Liquid peptides are the most sensitive, which is why they should ship overnight early in the week.